Spinout Active LTD

Company profile

Embody Orthopaedic Limited

UK company 08139224, incorporated on 11 July 2012.

Embody Orthopaedic

Embody Orthopaedic Limited is a UK company with status Active founded in 2012 based in London.

Company number
08139224
Incorporated
11 Jul 2012
Companies House status
Active

Company identity

Browse spinouts
Founded / incorporated
11 July 2012

Company number 08139224

Verify at Companies House
Legal name
EMBODY ORTHOPAEDIC LIMITED
Company type
Private Limited Company
Region
London
Registered address
EARLSFIELD BUSINESS CENTRE
9 LYDDEN ROAD
LONDON
UNITED KINGDOM
SW18 4LT
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

3 levels 1 ultimate controller
1
Company Active LTD
Embody Orthopaedic Limited
CRN 08139224
2
Direct controller
10313888
CRN 10313888
3
Intermediate controller Active LTD
4
Ultimate controller Active PLC
Ip Group PLC
CRN 04204490

Company events

Reference milestones and recent Companies House filing stream events.

5 events
25 Jul
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Apr
2027

Accounts due

Accounts Due

Next accounts due date

11 Jul
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jul
2025

Accounts filed

Accounts

Last accounts made up date

11 Jul
2012

Incorporated

Inception

Company registered at Companies House

Spinout profile

3 entries

Company description

Embody Orthopaedic designs and creates non-invasive nylon devices to assist orthopaedic surgery.

The company provides patient specific orthopaedic solutions. This primaily involves CT-based surgical planning and customised 3D printed instrumentation.

Project impact

n/a

Embody Orthopaedic
2012
Embody Orthopaedic
2012
Embody Orthopaedic Limited
2012

Public funding

3 awards
First funded
2013
Funded years
2013, 2015, 2017
Age at first award
1 years

Projects

2017 Feasibility Studies Lead participant

Clinically Proving the Feasibility of VPS on a Novel Substrate

1 Aug 2017 to 31 Oct 2018

Awarded
£104,332
Total cost £149,050

Coatings are used in the orthopaedic industry to encourage direct to implant bone ingrowth for long term stabilty. Coatings are proven on certain material groups, such as metal and plastic. We are proposing to clinical assess the feasibility of applying an ingrowth coating to a novel substrate, for which there is no clinical precendent. This will enable s...

2015 GRD Development of Prototype Lead participant

Development of a state of the art bone preserving metal- and cement-free hip implan t

1 Feb 2015 to 31 Oct 2016

Awarded
£123,638
Total cost £274,752

Hip resurfacing replacement is a bone sparing surgical procedure which treats painful osteoarthritis while restoring optimal hip functionality. This surgical procedure has been all but withdrawn in the UK owing to poorly designed implants leaking metal ions into patients. We have developed a novel non-metallic hip resurfacing implant which is inert in the...

2013 Collaborative R&D Lead participant

Transforming the high value joint replacement industry with additive manufacture

1 Oct 2013 to 30 Sep 2015

Awarded
£142,200
Total cost £237,000

We want to transform the delivery of knee replacement to the patient from traditional manufacturing practices, into a 'just-in-time' process. Currently every operation needs an entire inventory of prostheses and instrumentation; with our planned patient matched procedure, each patient will need a single 'pizza box' containing exactly what is needed for hi...

Product types

Collaborative R&D Feasibility Studies GRD Development of Prototype